STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

LeMaitre to Participate at Upcoming Investor Conferences in September

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

LeMaitre Vascular (Nasdaq: LMAT) has announced its participation in three major investor conferences this September. The company's management will be presenting at:

  • The Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024, in New York, with President David Roberts presenting at 5:35 PM EST.
  • The Barrington Research Fall Investment Conference (Virtual) on September 12, 2024, where Chairman & CEO George W. LeMaitre will host one-on-one meetings.
  • The Cantor Fitzgerald 2024 Global Healthcare Conference on September 19, 2024, in New York, with David Roberts presenting at 8:00 AM EST.

These conferences provide LeMaitre Vascular with opportunities to engage with investors and showcase their business strategies and performance.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

BURLINGTON, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in September.

Morgan Stanley 22nd Annual Global Healthcare Conference
Wednesday, September 4, 2024
New York Marriott Marquis, New York, NY
David Roberts, President, will present at 5:35 PM EST

Barrington Research Fall Investment Conference (Virtual)
Thursday, September 12, 2024
George W. LeMaitre, Chairman & CEO, is scheduled to host a series of 1x1 meetings

Cantor Fitzgerald 2024 Global Healthcare Conference
Thursday, September 19, 2024
InterContinental New York Barclay Hotel, New York, NY
David Roberts, President, will present at 8:00 AM EST

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. For more information about the Company, please visit www.lemaitre.com.

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.


FAQ

What investor conferences will LeMaitre Vascular (LMAT) attend in September 2024?

LeMaitre Vascular (LMAT) will attend three investor conferences in September 2024: Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, Barrington Research Fall Investment Conference on September 12, and Cantor Fitzgerald 2024 Global Healthcare Conference on September 19.

Who will represent LeMaitre Vascular (LMAT) at the Morgan Stanley Healthcare Conference in September 2024?

David Roberts, President of LeMaitre Vascular (LMAT), will represent the company and present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024, at 5:35 PM EST.

When and where will LeMaitre Vascular (LMAT) present at the Cantor Fitzgerald Global Healthcare Conference in 2024?

LeMaitre Vascular (LMAT) will present at the Cantor Fitzgerald 2024 Global Healthcare Conference on Thursday, September 19, 2024, at 8:00 AM EST. The conference will be held at the InterContinental New York Barclay Hotel in New York, NY.

What is the format of LeMaitre Vascular's (LMAT) participation in the Barrington Research Fall Investment Conference 2024?

At the Barrington Research Fall Investment Conference on September 12, 2024, which is a virtual event, George W. LeMaitre, Chairman & CEO of LeMaitre Vascular (LMAT), is scheduled to host a series of one-on-one meetings with investors.
Lemaitre Vasculr

NASDAQ:LMAT

LMAT Rankings

LMAT Latest News

LMAT Latest SEC Filings

LMAT Stock Data

1.90B
20.90M
7.8%
95.11%
5.96%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
BURLINGTON